ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.922,65
-0,79%
S&P 500
5.729,90
-0,81%
Dow Jones
42.544,27
-0,10%
Euro vs US Dollar
1,07822
-0,04%
Bitcoin
86.813,27
-0,75%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Amicus Therapeutics Inc (FOLD) Börsenkurse

Amicus Therapeutics Inc

Amicus Therapeutics Inc (FOLD)

NASDAQ
8,51
-0,11
( -1,28% )
Aktualisiert: 16:53:58
Verzögert um 15 Minuten
Fortg. Diagramm

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
8,51
Gebot
8,50
Fragen
8,51
Volumen
890.348
8,40 Tagesbereich 8,67
8,40 52-Wochen-Bereich 12,56
Marktkapitalisierung
2,554B
Handelsende
8,62
Handelsbeginn
8,63
Letzte Trade
100
@
8.51
Letzter Handelszeitpunkt
16:53:58
Finanzvolumen
US$ 7.553.645
VWAP
8,4839
Durchschnittliches Volumen (3 Mio.)
2.388.708
Ausgegebene Aktien
300.116.081
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-45,48
Gewinn pro Aktie (EPS)
-0,19
Erlöse
528,3M
Nettogewinn
-56,11M

Über Amicus Therapeutics Inc

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It... Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.amicusrx.com
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Amicus Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker FOLD. The last closing price for Amicus Therapeutics was US$8,62. Over the last year, Amicus Therapeutics shares have traded in a share price range of US$ 8,40 to US$ 12,56.

Amicus Therapeutics currently has 300.116.081 shares in issue. The market capitalisation of Amicus Therapeutics is US$2,59 billion. Amicus Therapeutics has a price to earnings ratio (PE ratio) of -45.48.

FOLD Neueste Nachrichten

Weitere Nachrichten

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
18 März 2025
FOLD (-1,28%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
22 Februar 2025
FOLD (-1,28%)

Form 8-K - Current report
Edgar (US Regulatory)
21 Februar 2025
FOLD (-1,28%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
21 Februar 2025
FOLD (-1,28%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
19 Februar 2025
FOLD (-1,28%)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Edgar (US Regulatory)
19 Februar 2025
FOLD (-1,28%)

Form 8-K - Current report
Edgar (US Regulatory)
19 Februar 2025
FOLD (-1,28%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.53-5.862831858419.049.268.430061058.84027982CS
4-0.56-6.174200661529.079.58.424764978.96429322CS
12-0.97-10.23206751059.48108.423887089.27136799CS
26-2.5-22.706630336111.0112.568.424382369.94927406CS
52-3.03-26.256499133411.5412.568.4249664010.27874132CS
156-0.87-9.27505330499.3814.575.91269947610.97167421CS
260-1.39-14.04040404049.925.395.91266634111.65018126CS

FOLD - Frequently Asked Questions (FAQ)

What is the current Amicus Therapeutics share price?
The current share price of Amicus Therapeutics is US$ 8,51
How many Amicus Therapeutics shares are in issue?
Amicus Therapeutics has 300.116.081 shares in issue
What is the market cap of Amicus Therapeutics?
The market capitalisation of Amicus Therapeutics is USD 2,59B
What is the 1 year trading range for Amicus Therapeutics share price?
Amicus Therapeutics has traded in the range of US$ 8,40 to US$ 12,56 during the past year
What is the PE ratio of Amicus Therapeutics?
The price to earnings ratio of Amicus Therapeutics is -45,48
What is the cash to sales ratio of Amicus Therapeutics?
The cash to sales ratio of Amicus Therapeutics is 4,83
What is the reporting currency for Amicus Therapeutics?
Amicus Therapeutics reports financial results in USD
What is the latest annual turnover for Amicus Therapeutics?
The latest annual turnover of Amicus Therapeutics is USD 528,3M
What is the latest annual profit for Amicus Therapeutics?
The latest annual profit of Amicus Therapeutics is USD -56,11M
What is the registered address of Amicus Therapeutics?
The registered address for Amicus Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Amicus Therapeutics website address?
The website address for Amicus Therapeutics is www.amicusrx.com
Which industry sector does Amicus Therapeutics operate in?
Amicus Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
PTPIPetros Pharmaceuticals Inc
US$ 0,209
(261,59%)
986,42M
OSRHOSR Holdings Inc
US$ 3,2989
(106,18%)
62,4M
VVPRVivoPower International PLC
US$ 3,9308
(73,93%)
117,52M
SURGSurgePays Inc
US$ 2,3477
(70,12%)
57,52M
ULYUrgent ly Inc
US$ 5,6848
(45,39%)
353,52k
BACKIMAC Holdings Inc
US$ 0,081
(-59,50%)
929,01k
ACRVAcrivon Therapeutics Inc
US$ 3,3879
(-37,14%)
758,06k
TNONTenon Medical Inc
US$ 2,54
(-32,27%)
15,26M
HUMAHumacyte Inc
US$ 2,0399
(-29,05%)
13,94M
ICGIntchains Group Ltd
US$ 3,00
(-27,18%)
101,6k
PTPIPetros Pharmaceuticals Inc
US$ 0,209
(261,59%)
986,42M
OCEAOcean Biomedical Inc
US$ 0,0794
(39,79%)
230,82M
LYTLytus Technologies Holdings PTV Ltd
US$ 0,0627
(23,91%)
141,54M
NVDANVIDIA Corporation
US$ 114,895
(-4,80%)
129,19M
VVPRVivoPower International PLC
US$ 3,9308
(73,93%)
117,52M

FOLD Finanzen

Finanzen

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
FOLD
Amicus Therapeutics
USOTC
ASDZF
Arctic Star Exploration (PK)
NYSE
ISEP
Innovator ETFs T
NASDAQ
ASPA
ABRI SPAC I
NASDAQ
OPTN
OptiNose
USOTC
AGRPY
Absa (PK)
USOTC
ADRLF
Adavale Resources (PK)
AQSE
TE21
Test Stock 21
Delayed Upgrade Clock
ADVFN Logo
Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten